Quit nicotine, get reconstruction: new study offers hope for breast cancer patients

NCT ID NCT06461650

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a nicotine cessation program can help women with breast cancer quit nicotine before reconstructive surgery. About 20 women who use nicotine and are scheduled for mastectomy or lumpectomy with reconstruction will take part. The program includes up to four counseling sessions over several weeks, and some may also use nicotine replacement therapy. The goal is to see if the program is feasible and acceptable, and whether it helps women become eligible for surgery that could improve their outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Nicotine cessation program (behavioral intervention)

What this could lead to

If successful, this program could help women quit nicotine before surgery, making them eligible for breast reconstruction and potentially reducing surgical complications.

What could go wrong

This is a very small feasibility study with only 20 participants, so results may not apply widely. The program's success depends on participants' motivation, and nicotine replacement therapy must be stopped before surgery, which may be challenging.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Florida

    RECRUITING

    Gainesville, Florida, 32608, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••